Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation

Annals of Surgical Oncology

Volumn 14, Issue 6, 2007, Pages 1890-1895

  Thompson, Margaret ^a   Korourian, Soheila ^a   Henry Tillman, Ronda ^a   Adkins, Laura ^a   Mumford, Sheilah ^a   Westbrook, Kent C ^a   Klimberg, V Suzanne ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

ALND; Lymphedema; SLNB

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; INJECTION SITE DISCOLORATION; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; LYMPHEDEMA; PROTECTION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TATTOO;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; LYMPHEDEMA; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 34249865348     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9412-x     Document Type: Article

References (40)

1. Ivens D, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1997; 66:136
2. Temple LK, Baron R, Cody HS 3rd, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002; 9(7):654-62
3. Somers RG, et al. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer; a prospective randomized trial. Ann Surg 1992; 215:146
4. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88:608-14
5. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002; 73(1):31-6
6. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002; 9(8):745-53
7. Blanchard DK, Donohue JH, Reynolds C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482-8
8. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341-50
9. Ronka R, von Smitten K, Tasmuth, et al. One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005; 14:28-36
10. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005; 92(1):23-31
11. Mansel R, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial: JNCI 2006; 98(9):599-609
12. Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 1998; 83:2817-20
13. Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychosocial morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 1993; 72:3248-52
14. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92(4):748-52
15. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13(4):491-500
16. Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 2004; 239(6):841-5; discussion 845-8
17. Descriptive Statistics. www.physics.csbsju.edu/stats/cstats NROW_form. Html
18. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 1970; 131:79
19. Fisher B, Fisher ER, Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of Lphenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 1986; 4:929
20. Giuliano A, Schwartz G. Summary of the proceedings of the Philadelphia Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Semin Breast Dis 2002; 5:110
21. Noguchi M, Taniya T, Ohta N, et al. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast. Breast Cancer Res Treat 1991; 19(1):23-31
22. http://www.cancer.org/downloads/STT/CAFF2006PWsecured.pdf
23. http://www.seer.cancer.gov/faststats/sites.php?site=Breast%20Cancer& stat=Incide nce
24. Bland K, Copeland E. The Breast: Comprehensive Management of Benign and Malignant Disorders, 3rd ed. St. Louis: Saunders, 2004
25. Kissin MW, della Rovere QG, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986; 73:580-4
26. Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 1987; 13:29-34
27. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12:1575-82
28. Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92:1368-77
29. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999; 177:184-7
30. Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20:4242-8
31. Silberman AW, McVay C, Cohen JS, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg 2004; 240:1-6
32. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92:748-52
33. Britton TM, Buczacki SJ, Turner CL, et al. Venous changes and lymphedema 4 years after axillary surgery for breast cancer. Br J Surg 2007; Epub Mar 2007
34. Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedema-what are the significant predictors and how they affect the severity of lymphedema. Breast J 2006; 12(6):536-43
35. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ. Sentinel Lymph Node Biopsy for Breast Cancer-Not Yet the Standard of Care. N Engl J Med. 1998; 339:990-995
36. Leidenius M, Leppanen E, Krogerus L, et al. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003; 185:127-30
37. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less post operative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002; 183:23-7
38. Rubio IT, Korourian S, Colvert M, Westbrook KC, Klimberg VS. Sentinel Lymph Node Biopsy for the Staging of Breast Cancer. Am J Surg 1998; 176(6):532-7
39. Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006; 15(3):153-65
40. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44(4):570-82